Navigation Links
Cellumen Establishes Collaboration in Breast Cancer Patient Stratification
Date:10/1/2007

PITTSBURGH, Oct. 1 /PRNewswire/ -- Cellumen, Inc. and Mayo Foundation for Medical Education and Research announced today the formation of a collaboration to apply cellular systems biology (CSB(TM)) profiling to breast cancer patient stratification. The goal is to create a breast cancer patient profile test to improve diagnosis and treatment for individualized medicine.

"We are very pleased to initiate an exciting research and development program with Mayo, a leader in individualized medicine," stated D. Lansing Taylor, Ph.D., CEO of Cellumen. "We are treating breast tumors as a 'system' within the breast cancer patient. A combination of breast cancer biomarkers and migratory immune cell biomarkers are being multiplexed in tissue micro-array (TMA) samples.

"We are enthusiastic about the synergy between Cellumen and Mayo in approaching this challenging opportunity," stated Taylor, "Mayo has great expertise and experience that will be applied to this collaboration. Cellumen continues to develop collaborations with the best in class partners to bring CSB solutions to the market."

About Cellumen

Cellumen, Inc. is the Cellular Systems Biology Company. Cellumen focuses on the cell as an integrated and interacting network of genes, proteins and metabolites responsible for normal and abnormal (disease) function. To promote efficient drug discovery and development, the company offers solutions to the dual challenges of efficacy and toxicity. The company's products and services have application in each of the major segments of the pharmaceutical pipeline: drug discovery ("cellular models of disease"), drug development ("cytotoxicity profiling") and clinical trials ("patient sample profiling"). The Cellumen team leverages its experience and expertise in High Content Screening, cell- based assays, advanced reagents and bioinformatics to create high value solutions. http://www.cellumen.com.


'/>"/>
SOURCE Cellumen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Strandware Founder Establishes Consulting Firm
2. RedPrairie Establishes Asia-Pacific Headquarters in Shanghai
3. West Coast VC Establishes Midwest Presence in Madison
4. Regional collaboration is key to states future
5. Cieslewicz, Barrett talk economic collaboration
6. Congress passes bill to ease researchers collaboration worries
7. Economic collaboration in Denver sets tall goal for Wisconsin
8. Better collaboration urged to further Wisconsin biotech
9. Southeastern Wisconsin Technology Collaboration
10. Big collaboration links learners to science on a tiny scale
11. UW-Madison releases open 3D collaboration environment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...VA, Calif., Nov. 5 Therm...r of innovative products for processing and storin... first quarter of fiscal 2010. ,, For the quart...revenues of $5.2 million, a 15 percent increase ov... year ago. The Company said the key contributors t...
(Date:11/5/2009)...Texas, Nov. 5 Wound Mana... that it has entered into a Letter of Intent to pu...alth Technologies, Inc. (OTC Bulletin Board: VHGI)... in cash and debt, 4,000,000 shares of WNDM and a ...n the Veriscrip technology being acquired from VHG...
(Date:11/5/2009)... Drug safety specialty firm BioSoteria anno...ormatics earned the Certified Professional in Lear... the American Society for Training and Development... has more than fifteen years of medical communicat...sponsible for the development of the company,s onl...
(Date:11/4/2009)...Ala., Nov. 4 DIATHERIX Laboratorie... presented at the Michigan Security Network Homela...rn, Mich. Dennis Grimaud, Chairman and Chief Execu... the company,s advanced molecular diagnostic testi...ous disease diagnosis and military efforts. ,,...
Breaking Biology Technology:ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4DIATHERIX Laboratories Presents at Homeland Security Conference 2
...rch 25 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex:...fourth quarter and year ended December 31, 2008. ,...ich we advanced a new business model focused on lo...gs. We achieved important milestones with our new ...vironment, we were unable to attract financing on ...
..., March 25 Insmed Inc. (Nasdaq: INSM ), a devel...ticals, today announced that on Monday, March 23, ... suspension of the rules requiring a minimum $1 cl...m market value of publicly held shares (MVPHS). T..., July 17, 2009, and the original rules will be re...
...h 25 /PRNewswire-FirstCall/ - Oncolytics Biotech I... announced the completion of patient enrolment in ...r effects of intravenous administration of REOLYSI...n patients with advanced cancers including breast,...e Dr. Johann de Bono of The Royal Marsden NHS Foun...
Other Biology Technology:ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 2ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 3ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 4ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 5ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 6ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 7Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 3
(Date:11/3/2009)..., , LAKE ALFRED, FLLaser labeling of fruit and ...a low-energy carbon dioxide laser beam is used to ...liminating the need for common sticker-type labels...riety of fruits and vegetables and is being used i...s. It has been been approved in Asia, South Africa...
(Date:11/3/2009)..., ,, WEST LAFAYETTE, Ind. - Chief executi...erpaid by about 129 times their "ideal salaries" i...lysis proposed by a Purdue University researcher t... most pressing economic and corporate governance i...ages for CEOs," said Venkat Venkatasubramanian, a ...
(Date:11/3/2009)..., , FORT COLLINS, COConsumer interest in new an...y factors including the growth of the "local foods...read reports touting its numerous health benefits,...increasing throughout the U.S. , While most groc... garlic (which is most often imported), varieties ...
Breaking Biology News(10 mins):Laser etching safe alternative for labeling grapefruit 2New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4Sustainably grown garlic 2Sustainably grown garlic 3superDimension Launches Second Generation iLogic 28TM 29Electromagnetic Navigation Bronchoscopy System to Detect and Diagnose Lung Cancer 5915 1superDimension Launches Second Generation iLogic 28TM 29Electromagnetic Navigation Bronchoscopy System to Detect and Diagnose Lung Cancer 5915 2superDimension Launches Second Generation iLogic 28TM 29Electromagnetic Navigation Bronchoscopy System to Detect and Diagnose Lung Cancer 5915 3Dr Julian Henley MD Presents BioMatrix Lift 5911 1Dr Julian Henley MD Presents BioMatrix Lift 5911 2Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies 5907 1Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies 5907 2
...t spring, the Vanderbilt greenhouse held more memb... known to exist in the wild., This unusual bounty ...ifer Ellis, a doctoral student in the biological s...of Professor David E. McCauley., The species is ca...cillatus. It was discovered in 1892 in Tennessee b...
...lfill the molecular requirements for sensing the m...und in retinal neurons of migratory birds (Mourits...tigating what parts of a migratory birds brain are...showed that the cryptochrome-containing neurons in...sen et al., PNAS, 2005; Liedvogel et al., EJN, 200...
... biologist and world-renowned expert on bird speci...ting into a recently published book, Speciation in...evolution at Chicago, evaluates the contributions ...speciation, and the roles of geographical isolatio...e discusses how nearly 10,000 bird species origina...
Other Biology News:Student study bolsters case for adding a rare sunflower to the endangered species list 2University biologist publishes book on bird speciation 2
...cent sequencing of Salmonella genomes has allowed ...mer PCR* primer pairs. The S. enterica Typhimurium...me (4,857,432 bp; 4,440 ORFs) and a plasmid, pSLT ...nosys have been designed to amplify all putative o...
...o-Stack Twister II Microplate Handler is a high-ca...n for integrating BioTeks washers, readers and liq...oplate capacity, ultimate flexibility and intuitiv...pacity to single devices or linking several module...
Goat Anti-XPLAC (S-17) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
STag Thrombin Purification Kit from Novagen
Biology Products: